4 Highly Profitable Stock You Can Choose to Creat Portfolio ( BIOF, CUR, SNSS, URZ )

Los Angelas, CA -- (SBWIRE) -- 09/14/2012 -- BioFuel Energy Co (NCM:BIOF) is very active today and traded between $4.185 - 6.65 with total traded volume of 1677047 shares. At a current price of 6.41, BIOF is +2.26 - +54.46% from the previous close of $4.15. Moreover, At Current Market Price, BIOF is in distance of +96.75% from its 50-day Moving Average price of $3.258 and -10.35% from its 200-day Moving Average price of $7.1501. Shares of BioFuel Energy Corp. soared more than 54 percent Thursday amid heavy trading.

The Denver-based ethanol company (BIOF) closed up 54.46 percent, or $2.26, to $6.41. That’s still off from its 52-week low, but stands out as 209 percent above its 52-week low. The ethanol maker is continuing its upwards climb following news on September 7 that prominent hedge fund manager David Einhorn raised his stake in the company by 11%.

What's The Next Target Of BIOF : Find Out Here

Neuralstem, Inc. (AMEX:CUR) is +0.38 - +38.00% from the previous close of $1.00. It traded between $1.00 - 1.96 with total traded volume of 15950761 shares. Keep a close eye on CUR, as the stock has been showing unusual moves over the past weeks. At Current market price, CUR has recovered +228.57% from its 52-week Low of 0.42 and has Pulled back -29.59% from its 52-week high of 1.96. Neuralstem, Inc.(NYSEAMEX:CUR) shares climbed 25% to $1.25. The company announced that Karl Johe, PhD, will give an update on the NSI-189 ongoing clinical trial in major depressive disorder (MDD) at the 6th Neurodegenerative Conditions Research and Development conference, September 13-14, in San Francisco, CA. Researchers severed the spinal vertebrae of 12 rats, then gave half of them Neuralstem’s stem cells a week after the injury, according to the study published today in the journal Cell. The rats that received the injections gained “significant locomotor recovery,” according to a company statement.

How Should Investors React CUR Now? Find Out Here

Sunesis Pharmaceu (NCM:SNSS) is +0.5883 - +15.48% from the previous close of $3.80. It traded between $3.79 - 4.41 with total traded volume of 4945373 shares. At Current Market Price, SNSSis in distance of +36.31% from its 50-day Moving Average price of $3.2194 and +54.16% from its 200-day Moving Average price of $2.8466. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS): After the company said that they are expanding a study of their cancer drug, Vosaroxin, shares of Sunesis Pharmaceuticals Inc. increased. Sunesis said they are adding 225 more patients for a total of 665 to a late-stage trial design which will test Vosaroxin as a treatment for acute Myeloid Leukemia in patients who have not responded well to one previous treatment. Sunesis said that the expansion was recommended by a committee of independent monitors who had reviewed early results from the trial.

What's The Next Target Of SNSS : Find Out Here

Uranerz Energy Co (AMEX:URZ) is +0.22 - +14.19% from the previous close of $1.55. It traded between $1.5499 - 1.83 with total traded volume of 2101555 shares. Keep a close eye on URZ, as the stock has been showing unusual moves over the past weeks. At Current market price, URZ has recovered +63.89% from its 52-week Low of 1.08 and has Pulled back -42.35% from its 52-week high of 3.07. Uranerz Energy Corp (NYSEAMEX: URZ) jumped up 10.32% to $1.71 on a traded volume of 354k shares. Last month, the Company has reported the receipt of further good uranium grades in wells drilled during the Nichols Ranch production well-field installation. The Company has drilled and cased 205 recovery and injection production wells in Production Area #1 of the Nichols Ranch ISR Mine as of August 15, 2012.

Can URZ Continue To Move Higher? Find Out Here

Disclaimer:
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com